These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Data on the staphylococcal anatoxin therapy of patients with coccogenous eczema]. KOROSSY S; DOBIAS G; BACKHAUSZ R; GOZONY M Orv Hetil; 1959 Jan; 100(4):134-9. PubMed ID: 13633294 [No Abstract] [Full Text] [Related]
3. [Investigations of the staphylococcic anatoxin-induced thrombocytopenia test in coccogenic eczemas]. KOROSSY S; GOZONY M Acta Allergol; 1958; 12(1):68-74. PubMed ID: 13507887 [No Abstract] [Full Text] [Related]
4. [Antistreptolysin, antistaphylolysin and anticoli titers in eczema]. SONCK CE; WIDHOLM O Nord Med; 1954 Jun; 51(25):849-52. PubMed ID: 13176755 [No Abstract] [Full Text] [Related]
5. [Allergy to staphylococcal anatoxin. III. Skin test for staphylococcal anatoxin following anatoxin therapy]. WAGNER V; MALY V Cas Lek Cesk; 1952 May; 91(22):646-9. PubMed ID: 14390245 [No Abstract] [Full Text] [Related]
6. On the occurrence and typing of Staphylococcus pyogenes in weeping eczema and the role played by these bacteria in the pathogenesis and course of eczema. ANDERSEN EK; HEILESEN B Acta Derm Venereol; 1951; 31(6):679-703. PubMed ID: 14914408 [No Abstract] [Full Text] [Related]
8. [Data on antigen (auto?) formation of the coccogenous complex and staphylogenous sensitization mechanism]. RAJKA O; KOROSSY S; GOZONY M Borgyogy Venerol Sz; 1957 Feb; 11(1):7-19. PubMed ID: 13426254 [No Abstract] [Full Text] [Related]
9. [Changes in the electrophoretic pattern of the blood serum of patients of staphylococcic pyodermitis after anatoxin therapy]. MOLINARI R; FERRUCCI M Arcisp S Anna Ferrara; 1957; 10(6):1559-63. PubMed ID: 13510072 [No Abstract] [Full Text] [Related]
10. [Evaluation of the Storck-Hoigne thrombocytopenia test in experimental animals]. DOBIAS G; KIRALY L; BERTALAN T Acta Allergol; 1962; 17():475-85. PubMed ID: 14028215 [No Abstract] [Full Text] [Related]
11. [Coccogenous eczema from the clinical immunological viewpoint]. Sándor K Orv Hetil; 1973 Jul; 114(26):1531-6. PubMed ID: 4577128 [No Abstract] [Full Text] [Related]
12. [Experiements and therapeutic studies with Micrococcus pyogenes anatoxin. II. Therapeutic results]. CSOKA E; BIRO L Borgyogy Venerol Sz; 1956 Mar; 10(2):73-7. PubMed ID: 13315533 [No Abstract] [Full Text] [Related]
13. [Generalized eczematization after positive epicutaneous test with a special strain of Micrococcus aureus and Streptococcus hemolyticus]. DOSSEKKER K; SCHLAPFER E Dermatologica; 1959; 118(4-5):315-6. PubMed ID: 13671904 [No Abstract] [Full Text] [Related]
14. [Comparison between the specific immunity obtained with plain staphylococcic anatoxin and with anatoxin treated with phosphorylated hesperidin]. RICHOU R; RICHOU H C R Hebd Seances Acad Sci; 1959 Jan; 248(2):321-3. PubMed ID: 13619169 [No Abstract] [Full Text] [Related]
15. [Result of the treatment of suppurative skin diseases with staphylococcal anatoxin A2]. SHEKLAKOV ND Vestn Venerol Dermatol; 1953; 5():15-7. PubMed ID: 13136814 [No Abstract] [Full Text] [Related]
16. [Use of staphylococcal anatoxin A2 in the treatment of pyoderma in miners]. ZATOLOKIN FD Sov Med; 1959 Apr; 23(4):130-1. PubMed ID: 13659205 [No Abstract] [Full Text] [Related]
17. [Use of staphylococcal anatoxin in therapy of suppurative surgical diseases of the skin and subcutaneous tissue]. ZEBRIN AG Khirurgiia (Mosk); 1957 Sep; 33(9):106-12. PubMed ID: 13492453 [No Abstract] [Full Text] [Related]